Delay in the administration of all-trans retinoic acid and its effects on early mortality in acute promyelocytic leukemia: Final results of a multicentric study in the United States

Armin Rashidi, Meghan Riley, Teresa A. Goldin, Farzaneh Sayedian, Michael G. Bayerl, Nadine S. Aguilera, Jeffrey A. Vos, Ranjit K. Goudar, Stephen I. Fisher

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Early death (ED) occurs in 10-30% of patients with acute promyelocytic leukemia (APL). Is all- trans retinoic acid (ATRA) promptly given and does it decrease overall early mortality? ATRA was administered within 24. h of morphological suspicion in only 44% of the 120 consecutive patients treated in the four collaborating centers. Absence of disseminated intravascular coagulation (p= 0.012) and admission to a non-university-affiliated hospital (p= 0.032) were independent predictors of ATRA delay. ED occurred in 17% of patients, and was independently correlated only with ICU admission (p= 0.002). Our results do not demonstrate that prompt (versus delayed) ATRA administration decreases overall early death.

Original languageEnglish (US)
Pages (from-to)1036-1040
Number of pages5
JournalLeukemia Research
Volume38
Issue number9
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Acute Promyelocytic Leukemia
Tretinoin
Mortality
Disseminated Intravascular Coagulation

Keywords

  • ATRA
  • Death
  • Leukemia
  • Promyelocytic

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Delay in the administration of all-trans retinoic acid and its effects on early mortality in acute promyelocytic leukemia : Final results of a multicentric study in the United States. / Rashidi, Armin; Riley, Meghan; Goldin, Teresa A.; Sayedian, Farzaneh; Bayerl, Michael G.; Aguilera, Nadine S.; Vos, Jeffrey A.; Goudar, Ranjit K.; Fisher, Stephen I.

In: Leukemia Research, Vol. 38, No. 9, 2014, p. 1036-1040.

Research output: Contribution to journalArticle

Rashidi, Armin ; Riley, Meghan ; Goldin, Teresa A. ; Sayedian, Farzaneh ; Bayerl, Michael G. ; Aguilera, Nadine S. ; Vos, Jeffrey A. ; Goudar, Ranjit K. ; Fisher, Stephen I. / Delay in the administration of all-trans retinoic acid and its effects on early mortality in acute promyelocytic leukemia : Final results of a multicentric study in the United States. In: Leukemia Research. 2014 ; Vol. 38, No. 9. pp. 1036-1040.
@article{15ec863ce79c490187b3998e5e0e6307,
title = "Delay in the administration of all-trans retinoic acid and its effects on early mortality in acute promyelocytic leukemia: Final results of a multicentric study in the United States",
abstract = "Early death (ED) occurs in 10-30{\%} of patients with acute promyelocytic leukemia (APL). Is all- trans retinoic acid (ATRA) promptly given and does it decrease overall early mortality? ATRA was administered within 24. h of morphological suspicion in only 44{\%} of the 120 consecutive patients treated in the four collaborating centers. Absence of disseminated intravascular coagulation (p= 0.012) and admission to a non-university-affiliated hospital (p= 0.032) were independent predictors of ATRA delay. ED occurred in 17{\%} of patients, and was independently correlated only with ICU admission (p= 0.002). Our results do not demonstrate that prompt (versus delayed) ATRA administration decreases overall early death.",
keywords = "ATRA, Death, Leukemia, Promyelocytic",
author = "Armin Rashidi and Meghan Riley and Goldin, {Teresa A.} and Farzaneh Sayedian and Bayerl, {Michael G.} and Aguilera, {Nadine S.} and Vos, {Jeffrey A.} and Goudar, {Ranjit K.} and Fisher, {Stephen I.}",
year = "2014",
doi = "10.1016/j.leukres.2014.06.011",
language = "English (US)",
volume = "38",
pages = "1036--1040",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Delay in the administration of all-trans retinoic acid and its effects on early mortality in acute promyelocytic leukemia

T2 - Final results of a multicentric study in the United States

AU - Rashidi, Armin

AU - Riley, Meghan

AU - Goldin, Teresa A.

AU - Sayedian, Farzaneh

AU - Bayerl, Michael G.

AU - Aguilera, Nadine S.

AU - Vos, Jeffrey A.

AU - Goudar, Ranjit K.

AU - Fisher, Stephen I.

PY - 2014

Y1 - 2014

N2 - Early death (ED) occurs in 10-30% of patients with acute promyelocytic leukemia (APL). Is all- trans retinoic acid (ATRA) promptly given and does it decrease overall early mortality? ATRA was administered within 24. h of morphological suspicion in only 44% of the 120 consecutive patients treated in the four collaborating centers. Absence of disseminated intravascular coagulation (p= 0.012) and admission to a non-university-affiliated hospital (p= 0.032) were independent predictors of ATRA delay. ED occurred in 17% of patients, and was independently correlated only with ICU admission (p= 0.002). Our results do not demonstrate that prompt (versus delayed) ATRA administration decreases overall early death.

AB - Early death (ED) occurs in 10-30% of patients with acute promyelocytic leukemia (APL). Is all- trans retinoic acid (ATRA) promptly given and does it decrease overall early mortality? ATRA was administered within 24. h of morphological suspicion in only 44% of the 120 consecutive patients treated in the four collaborating centers. Absence of disseminated intravascular coagulation (p= 0.012) and admission to a non-university-affiliated hospital (p= 0.032) were independent predictors of ATRA delay. ED occurred in 17% of patients, and was independently correlated only with ICU admission (p= 0.002). Our results do not demonstrate that prompt (versus delayed) ATRA administration decreases overall early death.

KW - ATRA

KW - Death

KW - Leukemia

KW - Promyelocytic

UR - http://www.scopus.com/inward/record.url?scp=84906936607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906936607&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2014.06.011

DO - 10.1016/j.leukres.2014.06.011

M3 - Article

C2 - 25035073

AN - SCOPUS:84906936607

VL - 38

SP - 1036

EP - 1040

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 9

ER -